Literature DB >> 15943034

Interleukin-15 and transforming growth factor alpha are associated with depletion of tumor-associated macrophages in colon cancer.

T Sasahira1, T Sasaki, H Kuniyasu.   

Abstract

We examined the effects of IL-15 and TGF-alpha on the inhibition of macrophage infiltration into colon cancer tissue, and secretion of amphoterin from colon cancer cells. Production of IL-15 and/or TGF-alpha was associated with depletion of tumor-associated macrophages (TAMs) in both Dukes' B and C tumors (P = 0.0324 and 0.0051, respectively). Production of IL-15 and/or TGF-alpha was also associated with amphoterin mRNA expression in colon cancer tissues with TAM depletion in both Dukes' B and C tumors (P = 0.0167 and P = 0.0062, respectively). WiDr human colon cancer cells treated with IL-15 and/or TGF-alpha induced reduction of nucleus-localized amphoterin and an increase in cytosolic and membranous amphoterin. Moreover, IL-15 and/or TGF-alpha treatment increased amphoterin secretion by WiDr cells. Most notably, IL-15 and TGF-alpha treatment induced the increase of cytosol/membrane localization and secretion of amphoterin and the most pronounced effect among the treatments carried out. These results suggested that IL-15/TGF-alpha promotes depletion of TAMs and secretion of amphoterin in colon cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943034

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  8 in total

1.  Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.

Authors:  Christian M Capitini; Terry J Fry; Crystal L Mackall
Journal:  Am J Immunol       Date:  2009-01-01

2.  Immunotherapy: rAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in mice.

Authors:  Giou-Teng Yiang; Horng-Jyh Harn; Yung-Luen Yu; Sheng-Chuan Hu; Yu-Ting Hung; Chia-Jung Hsieh; Shinn-Zong Lin; Chyou-Wei Wei
Journal:  J Biomed Sci       Date:  2009-05-07       Impact factor: 8.410

3.  Co-treatment with deoxycholic acid and azoxymethane accelerates secretion of HMGB1 in IEC6 intestinal epithelial cells.

Authors:  K Fujii; Y Luo; T Sasahira; A Denda; H Ohmori; H Kuniyasu
Journal:  Cell Prolif       Date:  2009-07-06       Impact factor: 6.831

Review 4.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 5.  Update of molecular pathobiology in oral cancer: a review.

Authors:  Tomonori Sasahira; Tadaaki Kirita; Hiroki Kuniyasu
Journal:  Int J Clin Oncol       Date:  2014-03-25       Impact factor: 3.402

Review 6.  From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors.

Authors:  Oana Draghiciu; Hans W Nijman; Toos Daemen
Journal:  Clin Dev Immunol       Date:  2011-12-08

Review 7.  The role of the cell-cell interactions in cancer progression.

Authors:  Katarzyna Kamińska; Cezary Szczylik; Zofia F Bielecka; Ewa Bartnik; Camillo Porta; Fei Lian; Anna M Czarnecka
Journal:  J Cell Mol Med       Date:  2015-01-19       Impact factor: 5.310

Review 8.  Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review.

Authors:  Austin Nguyen; Sheila Bhavsar; Erinn Riley; Gabriel Caponetti; Devendra Agrawal
Journal:  Int Arch Otorhinolaryngol       Date:  2016-04-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.